Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes
Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
To date one of the main independent biomarkers of cardiovascular disease is the arterial
stiffness measured by carotid-femoral pulse wave velocity. It is known that SGLT2 inhibitors
develop cardiac protection over long term administration.
Phase:
Phase 3
Details
Lead Sponsor:
Centro Universitario de Ciencias de la Salud, Mexico